This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here, Inc. And Cegedim, Inc. Form Strategic Alliance To Provide Instant Cash Rebates On Consumer Goods And Services And Pharmaceutical Products Nationwide

NEW YORK, April 2, 2013 /PRNewswire/ --, Inc. (OTCBB: GPCM) announced today that the OPUS HEALTH Division of Cegedim Inc. -- part of the billion dollar, global Cegedim Group led by Cegedim, SA (EURONEXT: CGM), entered into an Alliance Agreement with Grand Card, LLC, a subsidiary of the company, under which the two companies would implement a national roll out of an instant cash rebate card. A patent application was filed with the U.S. Patent and Trademark Office in August 2012.  

The "Grand Card" was developed to provide instant rebates on purchases of consumer goods and services and to consolidate prescription drug rebate offerings by multiple pharmaceutical manufacturers onto a single card. The cards will function as debit cards "pre-loaded" with instant cash rebates provided by manufacturers for purchases of consumer goods and services and pharmaceutical products at participating retail outlets and pharmacies. Applications for the Grand Card will be available in the second half of 2013 through affinity card issuers and on the website.

The company is currently in discussions with a number of strategic partners for distribution of the cards. To date, a number of Fortune 500 companies, manufacturers and service providers have executed letters of intent to participate in the program. The cards will be issued primarily through affinity programs with retailers, employers, unions and associations nationwide.

"We are proud to have been invited by to join forces as technology partner for the venture," said Paul Kandle, Vice President and General Manager of OPUS Health. "Each side brought important concept development ideas to the table, but the key to providing instant cash for buyers of prescriptions in the near term across the U.S. is that our technology is fully connected and operational at over 60,000 pharmacies. We will be expanding into retail outlets nationwide and, eventually, this opportunity could well grow into a global business, wherever debit cards are accepted."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,013.43 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs